MiR-137 is silenced in colorectal carcinoma, glioblastoma, neuroblastoma, prostate and pancreatic cancers.28, 29, 30, 31, 32 We therefore examined if miR-137 could decrease the ASCT2 abundance in tumor cells from these cancer types. Here, SLC1A5 is linked to familial pancreatic carcinoma.